We also included liver tissue sampled from patients with end‐stage PBC, PSC and AIH, which were classed as immune‐mediated liver diseases, where the immunological response might modulate expression levels of TWEAK and Fn14. The gene discussed is TNFRSF12A; the disease is primary biliary cholangitis.